About Baheal
Baheal Pharma Group is a healthcare industry group driven by technological innovation, with core businesses spanning medical innovation incubation, manufacturing, and commercialization. Leveraging deep insights into clinical needs and advanced incubation mechanisms, Baheal has established a Research and Development Platform through collaborating with leading national research institutions to discover original innovations based on basic biological R&D and innovative achievements investment incubation with First-in-Class potential. Baheal Pharma Group's listed subsidiary, Baheal Medical, as an industrialization platform with innovation brand-building capabilities, aims to accelerate the translation of medical innovations into clinical practice and improve patient outcomes. Today, Baheal has built a diversified portfolio across bone health, organ fibrosis, and brain metastases, and has successfully incubated multiple category-leading brands.

Social Responsibility

Innovation Incubation Platform
Baheal constantly strives to discover innovations with clinical applicability, to develop pharmaceutical brand commercialization platform and services with China's proprietary intellectual property rights, and to leverage technological innovation to optimize healthcare practices.
Back to Top